目录肽产品
OSTP-008A
Osteostatin (human)\n
H-Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-OH\nTrifluoroacetate salt
H-Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-OH\nTrifluoroacetate salt
Size：0.5
P1(RMB)：1000
MW：3451.62
One letter sequence：TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSR
Molecular Formula：C142H228N42O58
Description：This peptide is the carboxyl-terminal fragment of pTHrP, which is a potent inhibitor of osteoclastic bone resorption. It is suggested that this product acts directly on osteoclasts.
Literature Reference：A.J.Fenton et al., Endocrinology, 129, 1762 (1991)\nA.J.Fenton et al., Endocrinology, 129, 3424 (1991)
Cas：137348-10-8
P1(RMB)：1000
MW：3451.62
One letter sequence：TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSR
Molecular Formula：C142H228N42O58
Description：This peptide is the carboxyl-terminal fragment of pTHrP, which is a potent inhibitor of osteoclastic bone resorption. It is suggested that this product acts directly on osteoclasts.
Literature Reference：A.J.Fenton et al., Endocrinology, 129, 1762 (1991)\nA.J.Fenton et al., Endocrinology, 129, 3424 (1991)
Cas：137348-10-8
